Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03959293 |
|---|---|
| Brief Title: | Clinical Trial Evaluating FOLFIRI + Durvalumab vs FOLFIRI + Durvalumab and Tremelimumab in Second-line Treatment of Patients With Advanced Gastric or Gastro-oesophageal Junction Adenocarcinoma |
| First Submitted : | May 9, 2019 |
| First Submitted that Met QC Criteria : | May 21, 2019 |
| First Posted : | May 22, 2019 |
| Last Update Submitted that Met QC Criteria : | July 11, 2023 |
| Last Update Posted : | July 12, 2023 |